Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000198960 | SCV000249826 | likely benign | not specified | 2018-01-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV002229052 | SCV000283490 | likely benign | Ehlers-Danlos syndrome, classic type, 1 | 2025-01-02 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000387669 | SCV000478565 | uncertain significance | Ehlers-Danlos syndrome type 7A | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002315545 | SCV000738601 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2020-03-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Center for Human Genetics, |
RCV000680508 | SCV000807892 | uncertain significance | Connective tissue disorder | 2018-06-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000755967 | SCV000883656 | uncertain significance | not provided | 2018-03-04 | criteria provided, single submitter | clinical testing | The COL5A1 c.3983C>G; p.Pro1328Arg variant (rs140797509; ClinVar variant ID 212969), to our knowledge, is not reported in the medical literature, gene specific variation databases, nor has it been previously identified by our laboratory. This variant is listed in the genome Aggregation Database (gnomAD) with an overall population frequency of 0.04% (identified on 76 out of 179,884 chromosomes) and an Ashkenazi Jewish population frequency of 0.07% (identified on 61 out of 8,548 chromosomes). The proline at position 1328 is highly conserved, considering 12 species, and computational analyses of the effects of the p.Pro1328Arg variant on protein structure and function make conflicting predictions (SIFT: tolerated, PolyPhen-2: probably damaging). Based on the available information, the clinical significance of the p.Pro1328Arg variant cannot be determined with certainty. |
Illumina Laboratory Services, |
RCV001086728 | SCV001328145 | likely benign | Ehlers-Danlos syndrome, classic type | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Genome Diagnostics Laboratory, |
RCV002277479 | SCV002565737 | likely benign | Ehlers-Danlos syndrome | 2020-10-21 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000198960 | SCV004029944 | likely benign | not specified | 2023-07-21 | criteria provided, single submitter | clinical testing |